Annual Meeting Program 2024

ISAP 33rd
Annual Meeting

Live and Virtual

Friday, October 18, 2024
Philadephia, PA

2024 Program
Coming Spring 2024



ISAP 32nd Annual Meeting Program

0815–1800 Pacific Time Zone, USA

0815 – 0830 - ISAP Welcome/Announcements– Stuart Forman, MD

0830–1000 - Session 1 – Pharmacology
0830 – 0900
End-tidal anesthetic concentration: monitoring, interpretation, and clinical application.
Andre De Wolf, MD, Professor Emeritus, Northwestern University, Evanston, IL, USA

0900 – 0930
Gas Man® for Learning, Teaching, and Studying Inhalation Anesthesia Kinetic
James H. Philip, ME(E), MD, CCE, Anesthesiologist and Director of Clinical Bioengineering, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Medical Liaison for Anesthesia, Department of Biomedical Engineering, Partners HealthCare System, Professor of Anaesthesia, Harvard Medical School, Boston, MA, USA

0930 – 1000
Kalman Filtering in PKPD Modelling of Anaesthetic Drugs
Samaneh Nasiri, PhD, Harvard Medical School, Boston, MA, USA

1000-1015 - Break

1015 – 1145 - Session 2 – Anaesthesia and the Environmentt

1015 – 1045
Low Flow Anesthesia - 100 Years Later
Jeffrey Feldman, MD, MSE, Children’s Hospital of Philadelphia, University of Pennsylvania, PA, USA

1045 – 1115
Climate Impact of Volatile Anesthetics: Vital Insights for Anesthetists in the Era of Climate Change
Prof. Alain Kalmar, MD, PhD, Sint-Jan Hospital Brugge-Oostende, Belgium; Ghent University, Belgium

1115 – 1145
Action Guidance for Addressing Pollution from Inhalational Anaesthetics  
Jodi Sherman, MD, Yale School of Medicine, New Haven, CT, USA

1145-1300 - Luncheon – ISAP Business Meeting

1300 – 1400 - Session 3 – Up and Coming Anesthetics & Research
Effects of Site Concentration Guided Anesthesia with Analysis on Protocols of Clinical Outcomes for The Patient
Pether K Jildenstål, PhD, Associate Professor PhD, Lund University, Lund, Sweden
Henrik Öhrström, MD, Department of Anaesthesiology and Intensive Care, Örebro Univeristy Hospital, Örebro, Sweden
1400 – 1445 - Mohamed Naguib Lecture 
General Introduction on the Role of Pro-resolving Mediators (SPMs)

Charles N. Serhan, PhD, DSc, Gelman Professorship Harvard Medical School, Director Center for Experimental Therapeutics and Reperfusion Injury and Professor of Oral Medicine, Infection and Immunity, Brigham and Women's Hospital, Harvard University, Boston, MA, USA

1445-1500 - Break

1500– 1630 - Moderated Poster Session 90 minutes

1630-1645 - Break

1645 – 1730 - Keynote Speaker & Lifetime Achievement Awardee 
Anesthesia, the Eternal Loop Between Physiology and Pharmacology
Albert Dahan, MD, PhD, Full Professor of Anesthesiology, Head of Research, Head of the Anesthesia & Pain Research Unit, Staff Anesthesiologist, Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands

1730 – 1800 - Gathering

CME Information

Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by Amedco LLCand International Society for Anaesthetic Pharmacology. Amedco LLC is jointly accredited by theAccreditation Council for Continuing Medical Education (ACCME), the Accreditation Council forPharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to providecontinuing education for the healthcare team.Physicians

ACCME Credit Designation Statement: Amedco LLC designates this live activity for a maximum of 5.50 AMA PRA Category 1 CreditsTM for physicians. Physiciansshould claim only the credit commensurate with the extent of their participation in the activity.

CME Objectives, Practice Gaps, Educational Needs

Program Target Audience: This program is designed for an international audience of general anesthesiologists and anesthesiologists with a special interest in clinical pharmacology and technology.

Objectives of the Program: After attending this program you should be able to:

  1. Effectively understand the delivery and monitoring of anesthetic agents.
  2. Recognize new methods of PKPD modeling including Kalman Filtering.
  3. Obtain insight into the effects of inhaled anesthetics on the environment. 
  4. Explore methods of reducing the environmental impact of anesthetic agents.
  5. Appreciate new methods of anesthesia delivery including effect site concentration guided anesthesia and assess the clinical outcomes of these new methods.
  6. Learn about the role of pro-resolving mediators (SPMs) in anesthesiology.
  7. Recollect on the history of anesthesia and its melding of physiology and pharmacology.

Practice Gaps
• Anesthesiologists require information to understand, assess, and prevent the undesired effects of anesthetic drugs on the environment.

• Learning about monitoring and analytical techniques (such as effect-site concentration guidance, the role of proresolving mediators, and PKPD modelling techniques) help to expand therapeutic and research strategies.

• Understanding the delivery and monitoring of anesthetic delivery including the use of simulation helps to improve anesthetic practice.

Educational Needs
• Providing unbiased assessment and education for clinicians.

• Provide insight into future possibilities for improved clinical performance in anesthetic drug titration.